These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28579858)

  • 1. Cardiovascular Magnetic Resonance Imaging-Incremental Value in a Series of 361 Patients Demonstrating Cost Savings and Clinical Benefits: An Outcome-Based Study.
    Hegde VA; Biederman RW; Mikolich JR
    Clin Med Insights Cardiol; 2017; 11():1179546817710026. PubMed ID: 28579858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
    Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and United States health care systems.
    Moschetti K; Muzzarelli S; Pinget C; Wagner A; Pilz G; Wasserfallen JB; Schulz-Menger J; Nothnagel D; Dill T; Frank H; Lombardi M; Bruder O; Mahrholdt H; Schwitter J
    J Cardiovasc Magn Reson; 2012 Jun; 14(1):35. PubMed ID: 22697303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes.
    Ge Y; Pandya A; Steel K; Bingham S; Jerosch-Herold M; Chen YY; Mikolich JR; Arai AE; Bandettini WP; Patel AR; Farzaneh-Far A; Heitner JF; Shenoy C; Leung SW; Gonzalez JA; Shah DJ; Raman SV; Ferrari VA; Schulz-Menger J; Hachamovitch R; Stuber M; Simonetti OP; Kwong RY
    JACC Cardiovasc Imaging; 2020 Jul; 13(7):1505-1517. PubMed ID: 32417337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
    Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
    Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of cardiovascular magnetic resonance imaging compared to common strategies in the diagnosis of coronary artery disease: a systematic review.
    Azari S; Pourasghari H; Fazeli A; Ghorashi SM; Arabloo J; Rezapour A; Behzadifar M; Khorgami MR; Salehbeigi S; Omidi N
    Heart Fail Rev; 2023 Nov; 28(6):1357-1382. PubMed ID: 37532962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the "suspected CAD" cohort of the european cardiovascular magnetic resonance registry.
    Moschetti K; Petersen SE; Pilz G; Kwong RY; Wasserfallen JB; Lombardi M; Korosoglou G; Van Rossum AC; Bruder O; Mahrholdt H; Schwitter J
    J Cardiovasc Magn Reson; 2016 Jan; 18():3. PubMed ID: 26754743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine-stress cardiac magnetic resonance imaging in suspected coronary artery disease: a net cost analysis and reimbursement implications.
    Pilz G; Patel PA; Fell U; Ladapo JA; Rizzo JA; Fang H; Gunnarsson C; Heer T; Hoefling B
    Int J Cardiovasc Imaging; 2011 Jan; 27(1):113-21. PubMed ID: 20524070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of cardiovascular imaging for stable coronary heart disease.
    Walker S; Cox E; Rothwell B; Berry C; McCann GP; Bucciarelli-Ducci C; Dall'Armellina E; Prasad A; Foley JRJ; Mangion K; Bijsterveld P; Everett C; Stocken D; Plein S; Greenwood JP; Sculpher M
    Heart; 2021 Mar; 107(5):381-388. PubMed ID: 32817271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries.
    Moschetti K; Kwong RY; Petersen SE; Lombardi M; Garot J; Atar D; Rademakers FE; Sierra-Galan LM; Mavrogeni S; Li K; Fernandes JL; Schneider S; Pinget C; Ge Y; Antiochos P; Deluigi C; Bruder O; Mahrholdt H; Schwitter J
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):607-625. PubMed ID: 35033498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging.
    Ibrahim EH; Frank L; Baruah D; Arpinar VE; Nencka AS; Koch KM; Muftuler LT; Unal O; Stojanovska J; Rubenstein JC; Brown SA; Charlson J; Gore EM; Bergom C
    Int J Biomed Imaging; 2021; 2021():8851958. PubMed ID: 34054936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-centre survey of the application of cardiovascular magnetic resonance in clinical routine.
    von Knobelsdorff-Brenkenhoff F; Bublak A; El-Mahmoud S; Wassmuth R; Opitz C; Schulz-Menger J
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):62-8. PubMed ID: 22736714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK.
    Stokes EA; Doble B; Pufulete M; Reeves BC; Bucciarelli-Ducci C; Dorman S; Greenwood JP; Anderson RA; Wordsworth S
    BMJ Open; 2019 Jul; 9(7):e025700. PubMed ID: 31300495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation.
    Stukalova OV; Gupalo EM; Chumachenko PV; Samko AN; Butorova EA; Shakhnovich RM; Mironova NA; Narusov OY; Safiullina AA; Shariya MA; Golitsyn SP; Ternovoy SK; Chazova IE
    Ter Arkh; 2019 May; 91(4):28-36. PubMed ID: 31094473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cardiac magnetic resonance imaging on cardiac device and surgical therapy: a prospective study.
    Taylor AJ; Ellims A; Lew PJ; Murphy B; Pally S; Younie S
    Int J Cardiovasc Imaging; 2013 Apr; 29(4):855-64. PubMed ID: 23592405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease.
    Moschetti K; Favre D; Pinget C; Pilz G; Petersen SE; Wagner A; Wasserfallen JB; Schwitter JJ
    J Cardiovasc Magn Reson; 2014 Jan; 16(1):13. PubMed ID: 24461028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness and diagnostic yield of cardiac magnetic resonance imaging from a tertiary referral center in the Middle East.
    AlJaroudi W; Isma'eel H; El Merhi F; Assad T; Hourani M
    Cardiovasc Diagn Ther; 2015 Apr; 5(2):88-97. PubMed ID: 25984448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography.
    Pilz G; Bernhardt P; Klos M; Ali E; Wild M; Höfling B
    Clin Res Cardiol; 2006 Oct; 95(10):531-8. PubMed ID: 16897145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and prospective clinical validation of AI-based planning and shimming techniques in cardiac MRI.
    Edalati M; Zheng Y; Watkins MP; Chen J; Liu L; Zhang S; Song Y; Soleymani S; Lenihan DJ; Lanza GM
    Med Phys; 2022 Jan; 49(1):129-143. PubMed ID: 34748660
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.